Pasadena, CA, United States of America
Arrowhead Pharmaceuticals, Inc.
Patents = 95
Trademarks = 4
Forward Citations = 154
where 'Filed Patents' based on already Granted Patents
where 'Inventors Filed' based on already Granted Patents
169 inventors (with patents filed for the assignee):
Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company primarily focused on the development and commercialization of RNA interference (RNAi) therapeutics. They utilize their proprietary Targeted RNAi Molecule (TRiM) platform to design and develop RNAi-based drugs to treat various diseases. With a strong pipeline of innovative candidates, Arrowhead aims to address unmet medical needs and improve patient outcomes.
This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com